1. Home
  2. HBB vs VYGR Comparison

HBB vs VYGR Comparison

Compare HBB & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

HOLD

Current Price

$31.11

Market Cap

321.2M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$3.40

Market Cap

216.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HBB
VYGR
Founded
1904
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
321.2M
216.3M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
HBB
VYGR
Price
$31.11
$3.40
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
84.8K
404.1K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
2.75
N/A
Revenue
$606,852,000.00
$10,135,000.00
Revenue This Year
N/A
$34.04
Revenue Next Year
N/A
$7.92
P/E Ratio
$11.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.56
$2.94
52 Week High
$34.26
$5.55

Technical Indicators

Market Signals
Indicator
HBB
VYGR
Relative Strength Index (RSI) 54.76 56.22
Support Level $18.15 $3.33
Resistance Level $34.19 $3.56
Average True Range (ATR) 1.29 0.16
MACD -0.61 0.01
Stochastic Oscillator 23.68 74.03

Price Performance

Historical Comparison
HBB
VYGR

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products segment includes consumer product revenue consisting of sales of small electric household and specialty housewares appliances whereas the health segment includes lease revenue associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue which grant customers the right to use software for healthcare management.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: